Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EDOXABAN for Atrial fibrillation: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 3,855 adverse event reports in the FDA FAERS database where EDOXABAN was used for Atrial fibrillation.

Most Reported Side Effects for EDOXABAN

Side Effect Reports % Deaths Hosp.
Anaemia 663 8.0% 40 575
Cerebral infarction 419 5.0% 45 310
Gastrointestinal haemorrhage 378 4.5% 60 279
Renal impairment 359 4.3% 23 132
Cerebrovascular accident 337 4.0% 30 184
Dyspnoea 331 4.0% 24 256
General physical health deterioration 315 3.8% 15 293
Haematuria 312 3.7% 36 213
Fall 298 3.6% 39 237
Cardiac failure 272 3.3% 56 233
Melaena 255 3.1% 23 199
Dizziness 247 3.0% 24 156
Haematochezia 219 2.6% 10 183
Haemorrhage 216 2.6% 22 105
Off label use 211 2.5% 23 96

Other Indications for EDOXABAN

Product used for unknown indication (2,532) Deep vein thrombosis (404) Pulmonary embolism (307) Thrombosis prophylaxis (211) Anticoagulant therapy (169) Embolism venous (115) Thrombosis (87) Cerebral infarction (54) Cerebrovascular accident prophylaxis (53) Prophylaxis (48)

Other Drugs Used for Atrial fibrillation

RIVAROXABAN (52,584) DABIGATRAN ETEXILATE (20,492) APIXABAN (10,500) AMIODARONE (9,083) WARFARIN (8,680) ASPIRIN (2,993) DOFETILIDE (2,439) PRADAXA (2,325) METOPROLOL (1,542) BISOPROLOL (1,495)

Related Pages

EDOXABAN Full Profile All Atrial fibrillation Drugs EDOXABAN Demographics EDOXABAN Timeline